| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |